From curiosity about life on Earth to transformative therapies at Novartis. Michelle L Krishnan, Executive Director, MD PhD.

The word “biopsy” typically conjures images of large needles. Lab technicians—and scientists working to discover new medicines—need enough tissue from a patient to prepare and evaluate a sample.

A Novartis team blazes new trails with an experimental treatment for spinal muscular atrophy.

Novartis teams test combinations of targeted therapeutic agents to combat drug resistance in tumors.

A certain leggy resident of the African grasslands is arousing a lot of interest among evolutionary biologists. They believe that study of giraffes' unique features could lead the way to advances in human health.

Novartis is taking its investigational gene therapy for a degenerative eye disease into clinical trials.

An antibody that boosts muscle mass could mean independence for the frail and elderly. Learn how Novartis research aims to improve healthy aging.

Novartis has launched a comprehensive research program to help find the right combinations of therapies for the right patients.